載入...
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refractory multiple myeloma (RRMM) remains a challenge; the rational choice of the most appropriate regimen in this setting is currently undefined. We performed a systematic review and 2 standard pairwise m...
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5738982/ https://ncbi.nlm.nih.gov/pubmed/29296961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016003905 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|